美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

IntraLinks Holdings

13.01

+0.0000

成交量：- -

成交額：- -

市值：7.55億

市盈率：-37.17

高：13.01

開：13.01

低：13.01

收：13.01

資料載入中...

總覽公司新聞公告

我們為什麼投資Pendle？

三生國健(688336.SH)重組抗IL-4Rα人源化單克隆抗體注射液獲得藥物臨牀試驗批准通知書

流動性池：你需要知道的一切

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IL/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IL\",,,,,undefined,":{"symbol":"IL","market":"US","secType":"STK","nameCN":"IntraLinks Holdings","latestPrice":13.01,"timestamp":1575925200000,"preClose":13.01,"halted":4,"volume":0,"delay":0,"floatShares":40200000,"shares":58020000,"eps":-0.35,"marketStatus":"退市","change":0,"latestTime":"12-09 16:00:00 EST","open":13.01,"high":13.01,"low":13.01,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.35,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1281067200000,"exchange":"NYSE","adjPreClose":13.01,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IL\",,,,,undefined,":{"symbol":"IL","floatShares":40200000,"roa":"--","roe":"--","lyrEps":0,"shares":58020000,"dividePrice":0,"high":13.01,"amplitude":0,"preClose":13.01,"low":13.01,"week52Low":6.22,"pbRate":"2.85","week52High":13.72,"institutionHeld":0,"latestPrice":13.01,"eps":-0.35,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.35,"open":13.01},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IL\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2328074423","title":"我們為什麼投資Pendle？","url":"https://stock-news.laohu8.com/highlight/detail?id=2328074423","media":"Bixin Ventures","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2328074423?lang=zh_tw&edition=fundamental","pubTime":"2023-04-17 12:32","pubTimestamp":1681705975,"startTime":"0","endTime":"0","summary":"随著去中心化金融（DeFi）的不断成熟，这类收益的机会也将逐步增加。","market":"us","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.com/blockchain/3416844.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.jinse.com/blockchain/3416844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["IL","PT","BK4166"],"gpt_icon":0},{"id":"2327423112","title":"三生國健(688336.SH)重組抗IL-4Rα人源化單克隆抗體注射液獲得藥物臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2327423112","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2327423112?lang=zh_tw&edition=fundamental","pubTime":"2023-04-14 15:42","pubTimestamp":1681458128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生国健 公告，公司重组抗IL-4Rα人源化单克隆抗体注射液收到国家药品监督管理局核准签发的慢性鼻窦炎伴鼻息肉临床试验《药物临床试验批准通知书》，目前SSGJ-611在中国中重度特应性皮炎受试者中开展的一项II期临床研究已完成全部患者入组，并将于近期开展慢性鼻窦炎伴鼻息肉适应症的II期临床试验。据悉，SSGJ-611产品是公司创新研发，拥有自主知识产权的人源化抗IL-4Rα单克隆抗体，具有全新的氨基酸序列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/910582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688336","IL","BK0239","BK1576","03347","BK1583","BK1141"],"gpt_icon":0},{"id":"2280369396","title":"流動性池：你需要知道的一切","url":"https://stock-news.laohu8.com/highlight/detail?id=2280369396","media":"老雅痞","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2280369396?lang=zh_tw&edition=fundamental","pubTime":"2022-11-01 13:38","pubTimestamp":1667281134,"startTime":"0","endTime":"0","summary":"流动性池中需要多少代币流动性？在建立流动性池时，你需要考虑哪些因素？流动性池到底是如何运作的？","market":"hk","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.com/blockchain/2563599.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.jinse.com/blockchain/2563599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["IL"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-02","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":0.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1478059200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-05-03","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":0.01,"name":null,"time":"盤後","type":"earning","dateTimestamp":1462248000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-02-24","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":0,"name":null,"time":"盤後","type":"earning","dateTimestamp":1456290000000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2015-11-04","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":-0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1446613200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2015-08-05","symbol":"IL","fiscalQuarterEnding":null,"expectedEps":-0.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1438747200000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IL\",market:\"US\",delay:false,,,undefined,":{}}}